Here is what the page “HHS Moves to Allow Compounding of Unapproved Peptides Amid MAHA Push” contains. The Department of Health and Human Services is moving to permit compounding of certain unapproved peptides, a shift that aligns with Health Secretary Robert F. Kennedy Jr.'s 'Make America Healthy Again' agenda. The policy change could expand access to wellness compounds like BPC-157 and thymosin alp The policy change could expand access to wellness compounds like BPC-157 and thymosin alpha-1, which are popular in alternative medicine but lack robust clinical evidence for many claimed benefits.
Compounding pharmacies would gain a new market, while critics warn of safety risks and regulatory gaps. The move signals a broader embrace of peptides by federal health officials, despite ongoing debates over efficacy. This decision could reshape the supplement and compounding industries, with implications for patient safety and innovation. The full version stays on the original page, which this listing opens directly.